• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

TerrAscend Enters Into Agreements To Acquire State Flower, An Ultra-Premium California Cannabis Brand

Share:

September 3, 2019

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “the Company”) the first and only cannabis company with sales in Canada , the US and the EU, today announced the signing of definitive agreements for a series of transactions to purchase ABI SF, LLC, which operates a Bay Area cannabis cultivation facility and owns the State Flower brand (“State Flower”). State Flower is known for its ultra-premium cannabis flower and is currently sold through dispensaries in California and Nevada , including The Apothecarium. TerrAscend recently closed a series of transactions with The Apothecarium as noted in the Company’s press release of June 6, 2019 . By agreeing to purchase State Flower and bring aboard elite cultivation talent, TerrAscend will continue to provide high quality product through its retail locations and will expand the State Flower brand in multiple states

TerrAscend has agreed to initially acquire 49.9% of the equity of State Flower for total consideration of US$2.85M from conversion of a previously issued convertible debenture and subject to regulatory approvals.

TerrAscend has also extended a line of credit of up to US$3.75M to State Flower for cultivation facility improvements to expand production capacity. While State Flower implements facility improvements, the parties will begin the regulatory approval process for the full purchase of State Flower, under a Securities Purchase Agreement. TerrAscend also has future rights to use the State Flower brand pursuant to a license agreement.

TerrAscend has agreed to purchase the remaining 50.1% equity of State Flower for total consideration based on future revenue over a predetermined twelve-month period. The transaction is subject to regulatory approvals by various local and state authorities, as well as certain customary closing conditions. Several of the owners of The Apothecarium and their related entities have an ownership interest in State Flower.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We’re excited to add the prestigious State Flower brand to our portfolio,” said Matthew Johnson , President of TerrAscend Corp., and TerrAscend USA , Inc. ” Daniel Wacks and Jeremy Cohen are skilled cannabis cultivators with years of experience operating in a highly regulated market and we are thrilled to work with them to expand the State Flower facilities and brand presence. ”

“Through our work with The Apothecarium and TerrAscend, it’s clear that we’ve found a great strategic and cultural fit,” said Daniel Wacks , President of State Flower. “We’re proud of the brand we’ve built and excited to have found a partner who recognizes the quality of our team. We look forward to working together to build best-in-class cultivation capabilities in all jurisdictions where TerrAscend operates, to expand the State Flower brand presence, and become part of an inspirational team that’s making major progress towards becoming one of the top companies in the sector.”

Date: September 03, 2019

Source: Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ATC Alert LLC Acquires East Rock Medical Alert’s PERS AccountsATC Alert LLC Acquires East Rock Medical Alert’s PERS Accounts
  • Millie raises $4M for Tech-enabled maternity ClinicMillie raises $4M for Tech-enabled maternity Clinic
  • Canvas Medical Licenses Well being Gorilla’s FHIR-based API to Streamline Lab OrderingCanvas Medical Licenses Well being Gorilla’s FHIR-based API to Streamline Lab Ordering
  • Nanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health DealsNanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health Deals
  • AbCellera Lands Hottest Fishing Partner Yet in ModernaAbCellera Lands Hottest Fishing Partner Yet in Moderna
  • BioNovelus, Inc. Announces the Closing of its Acquisition of Corvus Consulting, LLCBioNovelus, Inc. Announces the Closing of its Acquisition of Corvus Consulting, LLC
  • Leica Biosystems Acquires Cell IDx, Moving Its Multiplexing Menu Forward With Ready-to-Use, Pre-Kitted FormulationsLeica Biosystems Acquires Cell IDx, Moving Its Multiplexing Menu Forward With Ready-to-Use, Pre-Kitted Formulations
  • Purdue Pharma L.P. Enters into Exclusive Option Agreement to Acquire SpineThera, Inc. and Its Non- Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back PainPurdue Pharma L.P. Enters into Exclusive Option Agreement to Acquire SpineThera, Inc. and Its Non- Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back Pain

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications